SAN DIEGO & PITTSBURGH--(BUSINESS WIRE)--Scientist.com, the world's leading marketplace for outsourced scientific services, and the University of Pittsburgh today announced a partnership that enables medical companies to access the latest translational research tools and technologies. The University offers an array of services to industry through Scientist.com, including computational modeling for pharmacology, drug target discovery services and translational technology development.
“Scientist.com’s award-winning marketplace will enable thousands of pharmaceutical and biotech researchers to access the outstanding suite of translational research services in Pitt’s School of Medicine,” stated Rebecca Bagley, Pitt’s Vice Chancellor for Economic Partnerships. “It is critical that industry and academia work together to lower barriers to innovation and bring new cures to market.”
The School of Medicine will be the first entity within Pitt to provide translational research services through Scientist.com. The University has created a centralized operation with a combination of academic and industrial experience to help its research facilities deliver outstanding basic science services to the medical industry.
"The School of Medicine is a hotbed of clinical and translational research," said Arthur S. Levine, MD, the John and Gertrude Petersen Dean of the School of Medicine. "Our faculty researchers have broad and deep scientific expertise, and we support their work with robust research infrastructure and a commitment to developing innovative tools and technologies. We also have a long track record of working with industry partners to speed the translation of scientific discoveries to the clinic and to the marketplace. I'm excited to see more such collaborations emerge from this partnership.”
Through Scientist.com, Pitt will create mutually beneficial, long-lasting partnerships with industry by providing fee-for-service access to its expert faculty and facilities. Scientist.com will serve as a time-saving liaison to match Pitt researchers with medical and pharmaceutical companies seeking research help on various projects such as new drug therapies or bioinformatics through a one-stop-shop database. Pitt’s research resources provide access to expertise, technology applications and state-of-the-art instruments that are otherwise unavailable to industry and many academic investigators.
“The University of Pittsburgh offers cutting-edge translational research tools as well as access to the experts needed to design and run a pre-clinical drug discovery program,” stated Kevin Lustig, PhD, Scientist.com’s CEO and Founder. “This partnership makes it easier for all scientists – academic, government and industry – to translate new research discoveries into therapeutic drug programs.”
Scientist.com is the world's leading marketplace for outsourced research. The marketplace simplifies the entire research sourcing process, saving time and money and providing access to the latest innovative tools and technologies while maintaining full compliance with an organization’s procurement policies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised more than $33 million from Leerink Transformation Partners, 5AM Ventures, Heritage Provider Network, Bootstrap Ventures and Hollywood producer Jack Giarraputo among others. Visit scientist.com to learn more. Join Scientist.com on social media: YouTube, LinkedIn, Twitter, Facebook, and Instagram.
About the University of Pittsburgh School of Medicine
The University of Pittsburgh School of Medicine has a mission to educate science-based, skilled, and compassionate clinicians prepared to meet the challenges of practicing medicine in the 21st century and conduct cutting-edge biomedical research that betters the human condition and advances the fundamental understanding of medical science. Part of the University since 1883, the school has places in history as a leader in medical treatments such as the polio vaccine and organ transplantation. The School of Medicine has annually ranked among the top 10 recipients of NIH funding since 1998, with $528 million in NIH grant funding awarded in 2017. The school also accounts for $551 million in funding received by the University. The School of Medicine has 579 registered MD students, including 315 (54 percent) women and 264 (46 percent) men. It also has 2,350 regular and 1,664 volunteer faculty members. Of these, 70 are current members of the Academy of Master Educators, an organization that recognizes and rewards excellence in medical education.